Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

A woman's hair loss was likely caused by a cream used for skin treatment and improved after she stopped using it.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

No treatment works for everyone, and emotional support is crucial.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Certain drugs can change hair color, either lightening or darkening it.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.